Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-01
2008-04-01
Coleman, Brenda L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
11347753
ABSTRACT:
The present invention is directed to amorphous form of indiplon, to processes for preparing said amorphous form, to pharmaceutical compositions containing the same, and to method of treatment using the same. Additionally, the present invention also relates to the preparation of solid amorphous dispersion of indiplon and a carrier which includes PVP and solid PEG etc.
REFERENCES:
patent: 4521422 (1985-06-01), Dusza et al.
patent: 6384221 (2002-05-01), Thiele et al.
patent: 6399621 (2002-06-01), Dusza et al.
patent: 6472528 (2002-10-01), Gross et al.
patent: 6544999 (2003-04-01), Thiele et al.
patent: 6903106 (2005-06-01), Zook et al.
patent: 6958342 (2005-10-01), Thiele et al.
patent: 2004/0116446 (2004-06-01), Zook et al.
Merck Index, 12th edition, p. 7733.
Lactel—Chemical and Physical Properties, <http://www.absorbables.com/properties.htm> downloaded Sep. 12, 2007.
Telko et. al. (Respiratory Care, 2005 50(9), 1209-1227.
Huang Hui Min He
Huang Le
Coleman Brenda L.
Mai De Ltd.
Moore Susanna
LandOfFree
Preparation of amorphous form of indiplon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of amorphous form of indiplon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of amorphous form of indiplon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3954091